Financing, Equity Capital Markets

Ocular Therapeutix, Inc.

12/20
|
$92.1 Million
Piper Sandler served as bookrunner for Ocular Therapeutix, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma